Cabergoline
PCT
Specifications Cabergoline:
Company: Hilma Biocare
Active Half-life (Hours): 62-70h
Group: Dopamine receptor agonists
Subgroup: Oral/tablets
Dosage: 0.25 mg/tab
Application (Men): 0.50mg weekly
Product pack: 10 tab.
Content (active): Cabergoline
Retains water: None
Aromatization: None
Product Description
Cabergoline is a dopaminergic derivative of ergoline and is characterized by a pronounced and long-lasting prolactin-lowering effect. Cabergoline affects the body by direct stimulation of D2-dopamine receptors on lactotroph cells in the pituitary gland. In bodybuilding, the drug is used to lower prolactin levels and eliminate the unwanted side effects of the anabolic supplement.
Effects:
With the help of Cabergoline athletes can reduce adverse reactions attributed to anabolic steroid use, including gynecomastia, water retention and high prolactin level. Additionally, it boosts sex drive, erection and recovery.
Side-Effects:
The most common side effects attributed to Cabergoline are headache, dizziness, nausea, sleepiness, emotional distress, and stomach pains.
Hilma Biocare™ takes care of consumers and regularly develops various means of protecting its products, which ensures patient safety and trust to verify our products
Want to be Hilma Biocare products Reseller?
Please contact our manager to discuss collaboration details directly via Message form.
Become a Partner